Summary & Overview
CPT 20974: Implantation of Electrical Bone Growth Stimulation Device
CPT code 20974 covers the surgical placement of a device that delivers electrical impulses directly to a fracture site to promote bone healing. This procedure is clinically relevant for patients with delayed union or nonunion of fractures and represents a targeted adjunct to surgical fracture management. Nationally, use of implantable electrical bone growth stimulators affects post-operative care pathways and payer coverage decisions given device and procedural costs.
Key payers included in the discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical indications and service setting, typical claims and billing considerations, common modifiers, and payer coverage patterns where available. The publication also summarizes benchmarks for utilization, identifies policy updates that influence reimbursement and prior authorization, and places the service in clinical context relative to alternative bone-healing therapies.
Data not available in the input for some fields is noted in the full content where applicable. The material is written for a national audience interested in clinical, billing, and policy aspects of implantable electrical bone growth stimulation represented by CPT code 20974.
Billing Code Overview
CPT code 20974 describes the placement of a device that emits electrical impulses at the site of a fractured bone to promote bone healing. This service is a form of therapeutic electrical stimulation intended to augment or stimulate osteogenesis at a nonunion or fracture site.
-
Service type: Implantation of an electrical bone growth stimulation device
-
Typical site of service: Operative setting, often performed in a procedure room or operating room at the fracture site
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or adolescent with a delayed union or nonunion of a long bone fracture (for example, tibia, femur, or humerus) following initial fixation or conservative treatment. The patient presents to an orthopedic clinic or ambulatory surgical center with persistent pain, radiographic evidence of inadequate callus formation, and functional limitation several months after the index fracture. The orthopedic surgeon evaluates imaging (plain radiographs, sometimes CT) and documents the diagnosis of delayed union or nonunion. After informed consent, the surgeon places a device that emits electrical impulses (implantable or external bone growth stimulator) at the fracture site to promote osteogenesis. The procedure is performed in the operating room or procedure suite when placement is invasive/implantable; in the clinic or outpatient setting when an external percutaneous lead or transcutaneous device is applied. Postprocedure workflow includes device programming, patient instruction on use and precautions, scheduling follow-up visits for wound/device check and serial imaging to document progression of bone healing, and coordination with durable medical equipment if an external stimulator is used for home therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal, uncomplicated service | Use when the procedure was performed without unusual circumstances and represents the standard service. |